BioNxt Solutions Inc. (OTCMKTS:BNXTF) Short Interest Update

BioNxt Solutions Inc. (OTCMKTS:BNXTF) was the target of a significant drop in short interest in February. As of February 13th, there was short interest totaling 1,100 shares, a drop of 45.5% from the January 29th total of 2,018 shares. Approximately 0.0% of the shares of the stock are sold short. Based on an average daily trading volume, of 1,935 shares, the days-to-cover ratio is presently 0.6 days. Based on an average daily trading volume, of 1,935 shares, the days-to-cover ratio is presently 0.6 days. Approximately 0.0% of the shares of the stock are sold short.

BioNxt Solutions Stock Performance

Shares of OTCMKTS BNXTF opened at $0.46 on Monday. The company has a market cap of $55.77 million, a price-to-earnings ratio of -11.38 and a beta of 0.81. BioNxt Solutions has a 12 month low of $0.24 and a 12 month high of $0.80. The stock has a 50-day moving average price of $0.44 and a two-hundred day moving average price of $0.54.

BioNxt Solutions (OTCMKTS:BNXTF) last posted its quarterly earnings results on Friday, November 28th. The company reported ($0.01) earnings per share for the quarter. The firm had revenue of $0.01 million for the quarter.

BioNxt Solutions Company Profile

BioNxt Solutions Inc (OTCMKTS:BNXTF) is a life sciences company specializing in advanced proteomics, metabolomics and bioinformatics solutions. The company’s platform combines state-of-the-art mass spectrometry and chromatography workflows with cloud-based data analysis tools, enabling high-throughput characterization of proteins, metabolites and other biomolecules for research and development purposes.

BioNxt Solutions offers contract research services to clients in the pharmaceutical, biotechnology and academic sectors, providing end-to-end support from sample preparation through to data interpretation.